TCL Archive Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines January 13, 2012
TCL Archive FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer April 29, 1988
TCL Archive Also in this 8-page issue: John Niederhuber joins NCI as special advisor, quits NCAB. Harold Freeman steps down as NCI disparities head. September 9, 2005
TCL Archive Phase III Tumor Treating Fields Trial Halted Following Positive Results in Interim Analysis November 28, 2014
